These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 18240747)

  • 1. DNA promoter hypermethylation in saliva for the early diagnosis of oral cancer.
    Viet CT; Jordan RC; Schmidt BL
    J Calif Dent Assoc; 2007 Dec; 35(12):844-9. PubMed ID: 18240747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
    Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
    Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promoter hypermethylation and expression profile of MGMT and CDH1 genes in oral cavity cancer.
    Kordi-Tamandani DM; Moazeni-Roodi AK; Rigi-Ladiz MA; Hashemi M; Birjandian E; Torkamanzehi A
    Arch Oral Biol; 2010 Oct; 55(10):809-14. PubMed ID: 20674887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoter methylation of TIMP3 and CDH1 predicts better outcome in head and neck squamous cell carcinoma treated by radiotherapy only.
    De Schutter H; Geeraerts H; Verbeken E; Nuyts S
    Oncol Rep; 2009 Feb; 21(2):507-13. PubMed ID: 19148529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant methylation of multiple genes in gastric carcinomas.
    Zhao YF; Zhang YG; Tian XX; Juan Du ; Jie Zheng
    Int J Surg Pathol; 2007 Jul; 15(3):242-51. PubMed ID: 17652530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High frequency of hypermethylation of p14, p15 and p16 in oral pre-cancerous lesions associated with betel-quid chewing in Sri Lanka.
    Takeshima M; Saitoh M; Kusano K; Nagayasu H; Kurashige Y; Malsantha M; Arakawa T; Takuma T; Chiba I; Kaku T; Shibata T; Abiko Y
    J Oral Pathol Med; 2008 Sep; 37(8):475-9. PubMed ID: 18284544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relevance of MSP assay for the detection of MGMT promoter hypermethylation in glioblastomas.
    Yachi K; Watanabe T; Ohta T; Fukushima T; Yoshino A; Ogino A; Katayama Y; Nagase H
    Int J Oncol; 2008 Sep; 33(3):469-75. PubMed ID: 18695875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p16(INK4a) promoter hypermethylation in oral scrapings of oral squamous cell carcinoma risk patients.
    Ruesga MT; Acha-Sagredo A; Rodríguez MJ; Aguirregaviria JI; Videgain J; Rodríguez C; de Pancorbo Mde L; Aguirre JM
    Cancer Lett; 2007 May; 250(1):140-5. PubMed ID: 17113222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study of aberrant methylation of TSG in saliva in case of upper-aerodigestive-tract cancer].
    Righini CA; de Fraipont F; Timsit JF; Dassonville O; Milano G; Moro-Sibilot D
    Rev Stomatol Chir Maxillofac; 2008 Sep; 109(4):226-32. PubMed ID: 18760810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylation of the MGMT and p16 genes in sporadic colorectal carcinoma and corresponding normal colonic mucosa.
    Krakowczyk L; Strzelczyk JK; Adamek B; Zalewska-Ziob M; Arendt J; Półtorak S; Maciejewski B; Wiczkowski A
    Med Sci Monit; 2008 Oct; 14(10):BR219-25. PubMed ID: 18830187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative promoter hypermethylation analysis of cancer-related genes in salivary gland carcinomas: comparison with methylation-specific PCR technique and clinical significance.
    Lee ES; Issa JP; Roberts DB; Williams MD; Weber RS; Kies MS; El-Naggar AK
    Clin Cancer Res; 2008 May; 14(9):2664-72. PubMed ID: 18451230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of molecular markers and extent of resection in primary glioblastoma patients.
    Felsberg J; Rapp M; Loeser S; Fimmers R; Stummer W; Goeppert M; Steiger HJ; Friedensdorf B; Reifenberger G; Sabel MC
    Clin Cancer Res; 2009 Nov; 15(21):6683-93. PubMed ID: 19861461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promotor hypermethylated genes: Prospective diagnostic biomarkers in oral cancerogenesis.
    Dvojakovska S; Popovic-Monevska D; Grcev A; Pancevski G; Benedetti A; Popovski V; Dimovski A; Stamatoski A
    J Craniomaxillofac Surg; 2018 Oct; 46(10):1737-1740. PubMed ID: 30100382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative detection of promoter hypermethylation of multiple genes in the tumor, urine, and serum DNA of patients with renal cancer.
    Marshall FF
    J Urol; 2005 Jun; 173(6):1918. PubMed ID: 15879775
    [No Abstract]   [Full Text] [Related]  

  • 15. Hypermethylation of the p15INK4B gene promoter in B-chronic lymphocytic leukemia.
    Papageorgiou SG; Lambropoulos S; Pappa V; Economopoulou C; Kontsioti F; Papageorgiou E; Tsirigotis P; Dervenoulas J; Economopoulos T
    Am J Hematol; 2007 Sep; 82(9):824-5. PubMed ID: 17546638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant methylation of APC, MGMT, RASSF2A, and Wif-1 genes in plasma as a biomarker for early detection of colorectal cancer.
    Lee BB; Lee EJ; Jung EH; Chun HK; Chang DK; Song SY; Park J; Kim DH
    Clin Cancer Res; 2009 Oct; 15(19):6185-91. PubMed ID: 19773381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant promoter hypermethylation in serum DNA from patients with silicosis.
    Umemura S; Fujimoto N; Hiraki A; Gemba K; Takigawa N; Fujiwara K; Fujii M; Umemura H; Satoh M; Tabata M; Ueoka H; Kiura K; Kishimoto T; Tanimoto M
    Carcinogenesis; 2008 Sep; 29(9):1845-9. PubMed ID: 18632757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of novel myeloid precursor cell line, PC-MDS, established from a bone marrow of the patient with therapy-related myelodysplastic syndrome.
    Bogdanović G; Jurisić V; Kraguljac N; Mrdjanović J; Jakimov D; Krtolica K; Krajnović M; Magić Z; Stojiljković B; Andrijević L; Srdić T; Baltić M; Popović S
    Leuk Res; 2007 Aug; 31(8):1097-1105. PubMed ID: 17350682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between MGMT promoter hypermethylation and p53 mutation in glioblastoma.
    Shamsara J; Sharif S; Afsharnezhad S; Lotfi M; Raziee HR; Ghaffarzadegan K; Moradi A; Rahighi S; Behravan J
    Cancer Invest; 2009 Oct; 27(8):825-9. PubMed ID: 19544111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant promoter hypermethylation in biliary tract carcinoma.
    Kohya N; Koga Y; Kitajima Y; Miyazaki K
    J Hepatobiliary Pancreat Surg; 2006; 13(4):296-305. PubMed ID: 16858540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.